Position in NBIX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$30,760,908
+$8,926,980 QoQ
Shares Held
182,514
+10.1% QoQ
Ownership
0.180%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#85
of 768 holders
Holding Since
Mar 2020
22 quarters on record
Voting authority
Sole 98%
Shared 0%
None 2%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026LOOMIS SAYLES & CO L P holds $224,982,288 across 8 Drug Manufacturers - Specialty & Generic names. NBIX ranks #3 (13.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALKS |
Alkermes plc.
|
1,585,518 | $83,081,142 | |
| 2 | SUPN |
Supernus Pharmaceuticals, Inc.
|
1,475,192 | $68,611,179 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
This page
|
182,514 | $30,760,908 | |
| 4 | LNTH |
Lantheus Holdings, Inc.
|
141,424 | $15,689,578 | |
| 5 | ANIP |
Ani Pharmaceuticals Inc
|
162,792 | $13,475,921 | |
| 6 | COLL |
Collegium Pharmaceutical, Inc
|
364,999 | $13,212,963 | |
| 7 | UTHR |
UNITED THERAPEUTICS Corp
|
255 | $138,166 | |
| 8 | ZTS |
Zoetis Inc.
|
173 | $12,431 |
All Filings in NBIX
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $30,760,908 | 182,514 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $21,833,928 | 165,735 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $24,000,471 | 169,220 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $22,575,349 | 160,816 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $17,657,433 | 140,484 | Shares | Defined | 2025-08-13 | |
| 2024-09-30 | $17,321,828 | 150,337 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $22,064,370 | 160,270 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $35,160,359 | 254,933 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $33,713,298 | 255,869 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $28,904,174 | 256,926 | Shares | Defined | 2023-11-09 | |
| 2023-06-30 | $19,533,207 | 207,139 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $16,499,163 | 163,003 | Shares | Defined | 2023-05-15 | |
| 2022-09-30 | $202,861 | 1,910 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $200,028 | 2,052 | Shares | Defined | 2022-08-05 | |
| 2022-03-31 | $190,593 | 2,033 | Shares | Defined | 2022-05-13 | |
| 2021-09-30 | $25,929,747 | 270,355 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $25,578,031 | 262,824 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $24,555,333 | 252,497 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $24,165,701 | 252,120 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $19,558,846 | 203,399 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $22,631,854 | 185,507 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $14,812,599 | 171,145 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||